ABSTRACT
Objectives Evaluating craniofacial phenotype-genotype correlations prenatally is increasingly important; however, it is subjective and challenging with 3D ultrasound. We developed an automated landmark propagation pipeline using 3D motion-corrected, slice-to-volume reconstructed (SVR) fetal MRI for craniofacial measurements.
Methods A literature review and expert consensus identified 31 craniofacial biometrics for fetal MRI. An MRI atlas with defined anatomical landmarks served as a template for subject registration, auto-labelling, and biometric calculation. We assessed 108 healthy controls and 24 fetuses with Down syndrome (T21) in the third trimester (29-36 weeks gestational age, GA) to identify meaningful biometrics in T21. Reliability and reproducibility were evaluated in 10 random datasets by four observers.
Results Automated labels were produced for all 132 subjects with a 0.03% placement error rate. Seven measurements, including anterior base of skull length and maxillary length, showed significant differences with large effect sizes between T21 and control groups (ANOVA, p<0.001). Manual measurements took 25-35 minutes per case, while automated extraction took approximately 5 minutes. Bland-Altman plots showed agreement within manual observer ranges except for mandibular width, which had higher variability. Extended GA growth charts (19-39 weeks), based on 280 control fetuses, were produced for future research.
Conclusion This is the first automated atlas-based protocol using 3D SVR MRI for fetal craniofacial biometrics, accurately revealing morphological craniofacial differences in a T21 cohort. Future work should focus on improving measurement reliability, larger clinical cohorts, and technical advancements, to enhance prenatal care and phenotypic characterisation.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by the NIHR clinical doctoral research fellowship to JM (NIHR300555) – the European Research Council under the European Union’s Seventh Framework Programme ([FP7/ 20072013]/ERC grant agreement no. 319456) for the dHCP project – the Wellcome Trust and EPSRC IEH award [102431] for the iFIND project and the Wellcome/EPSRC Centre for Medical Engineering at King’s College London [WT 203148/Z/16/Z] – the NIH (Human Placenta Project [grant 1U01HD087202-01]) for the PIP study – NIHR Advanced Fellowship awarded to Lisa Story [NIHR30166]– the Medical Research Council grant [MR/X010007/1]. This paper represents independent research part funded by the National Institute for Health and Care Research (NIHR) – the NIHR Clinical Research Facility at Guy’s and St Thomas’ and by the Maudsley Biomedical Research Centre (BRC) at South London and Maudsley NHS Foundation Trust and King’s College London. J.O. and M.R. received support from the Medical Research Council Centre for Neurodevelopmental Disorders, King’s College London (Grant MR/N026063/1). J.O. is supported by a Sir Henry Dale Fellowship jointly funded by the Wellcome Trust and the Royal Society (Grant 206675/Z/17/Z).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The following relevant datasets were given research ethics committee (REC) approval by the Health Research Authority: The Placental Imaging Project (REC no. 14/LO/1169) – the Intelligent Fetal Imaging and Diagnosis (REC no. 14/LO/1806) – the quantification of fetal growth and development with MRI study (REC no. 07/H0707/105) – the fetal CMR service at Evelina London Children’s Hospital (REC no. 07/H0707/105) – the developing human connectome project (REC no 14/LO/1169) – the early brain imaging in Down syndrome study (REC no. 19/LO/0667) – the Individualised risk prediction of adverse neonatal outcome in pregnancies that deliver preterm using advanced MRI techniques and machine learning study (REC no. 21/SS/0082) – and the Cardiac and Placental Imaging in Pregnancy project (REC no. 08/LO/1958).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data availability statement
Fetal MRI datasets used for this study are not publicly available due to ethics regulations. The proposed biometry protocol defined in the 3D T2w atlas space and craniofacial growth charts are publicly available online at KCL CDB fetal MRI atlas repository: https://gin.g-node.org/kcl_cdb/craniofacial_fetal_mri_atlas.
